Pharmacy Healthcare Solutions Inc. (PHSI) consults with pharmaceutical manufacturers, PBMs, retail pharmacy chains, and software companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSI with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.
PHSI President Tim Kosty, Vice President Don Dietz, and many of PHSI’s consultants will be attending the 2016 NACDS Total Store Expo in Boston, MA on August 6-9. PHSI will have an exhibit set up at booth number 1758. If you would like to schedule a meeting with a PHSI team member, please click here to send us Read More →
Spring 2016 Newsletter CMS’s Proposed New Part B Payment Model Medicare Part B drug reimbursement to physicians and hospital outpatient centers has been in the spotlight for the past few years. Average Sale Price (ASP) pricing reimbursement methodology and the increased approval of more office-administered drugs has dramatically increased spending on Part B drugs. Currently, Read More →
Spring 2016 PHSI Newsletter OTCs vs. Supplements When patients visit the front-end of the pharmacy, most assume that the FDA approves all products on the shelf for safety and efficacy. Patients do not distinguish between over-the-counter (OTC) drugs, vitamins, and dietary supplements. Supplements such as fish oil and ginseng, OTC drugs like acetaminophen, and vitamins Read More →
Update: The most recent DEA National Prescription Drug Take-Back Day on April 30th was the most successful event in the history of the program. Expectations were far surpassed as a total of 893,498 pounds or 447 tons of prescription medication were recovered across the country. The states with the most amounts of medications surrendered included Read More →
Pharmacists’ services continue to expand as pharmacists are getting involved in prescribing and/or furnishing certain medications, such as hormonal contraceptives, in several states. Listed below is the latest information on initiatives underway in Oregon and California. Oregon Pharmacists in Oregon can now prescribe and dispense hormonal contraceptives, both oral and transdermal. While the Oregon Board Read More →
2015 was a banner year for novel drugs approved. There were 45 novel drugs approved as new molecular entities (NME) under New Drug Applications (NDAs) or Biologics License Applications (BLAs) in 2015, up from 41 novel drugs approved in 2014. As a comparison, the FDA has averaged 28 novel drug approvals per year in the Read More →